Page 846 - Adams and Stashak's Lameness in Horses, 7th Edition
P. 846

812   Chapter 7


            proteoglycans (aggrecan, decorin, fibromodulin, link pro­    demonstrated cleavage of HA by free radicals. 32,116  There
                                                    25
            tein) and type IV, V, VII, IX, and XI collagen.  It also   is also evidence that superoxide can degrade the alpha
  VetBooks.ir  of IL‐1‐induced cartilage degeneration has revealed evi­  treatment inhibits gelatin.  Proteoglycans may be
                                                               chains of collagen based on the finding that superoxide
            cleaves type II collagen in nonhelical sites.  In vitro study
                                              118
                                                                                        31
                                                               cleaved by free radicals.  Increased free radicals in the
            dence of collagen degradation that could be attributed to
                                                                                    31
            stromelysin in addition to that attributed to collagenase.    synovial fluid of cases of equine joint disease have been
                                                           21
            Molecular cloning and cartilage gene expression of equine   demonstrated more recently. 20
            stromelysin 1 (MMP‐3) has been described by Balkman   Nitric oxide has been recognized as an important
            and Nixon.  Stromelysin cleaves the protein backbone of   physiologic mediator. It combines avidly with superoxide
                      2
            cartilage proteoglycans at the asparagine 341–phenylala­  anion, and although this was originally thought to pro­
            nine 342 bond.  Cleavage due to aggrecanase, on the other   vide a protective function, it has been suggested that this
                        57
                                               68
            hand, occurs at the GLU373‐ALA373 site.  Based on pre­  reaction can generate further destructive species, includ­
            liminary work in the horse using markers that differentiate   ing peroxynitrite anion and hydroxyl radicals.  A recent
                                                                                                       81
            these two cleavage sites, it appears that aggrecanase is the   review has noted that the specific effect of a radical on a
            principal enzyme degrading proteoglycan in equine joint   given cell function very much depends on experimental
            disease. 51                                        context. Specifically, the simultaneous presence of super­
              Equine MMPs 2 and 9 are two gelatinases that have   oxide, which leads to the formation of peroxynitrite (due
            been characterized in the horse. 11,12  It is known that the   to interaction of NO and supraoxide), a stronger and
            one‐fourth and three‐fourth fragments generated by   highly reactive radical, is likely to lead to cell and tissue
            cleavage by fibrin or collagens by collagenases can   damage.  However, NO has certain protective effects in
                                                                       53
            unwind and are then susceptible to further cleavage by   cartilage and other tissues, and inhibition of NO in vitro
            MMP‐2 and MMP‐9. MMPs 2 and 9 are produced by a    or in vivo can potentially lead to undesired exacerbation
            variety of equine cell types, and these enzymes have been   of inflammation and tissue destruction under certain con­
            demonstrated in elevated levels in synovial fluids from   ditions. Selective scavengers of peroxynitrite must be
            horses with joint disease. 11,12                   more promising candidates for the treatment of OA than
              The  metalloproteinases  are  inhibited  by  two tissue   specific inhibition of NO. The role of nitric oxide in joint
            inhibitors of metalloproteinase and these are known   disease needs, and is receiving, further attention.
            commonly as TIMP (TIMP‐1 and TIMP‐2). 75,102  TIMP is
            found in many connective tissues and may be the most
            important inhibitor found in articular cartilage.  This   Cytokines and Articular Cartilage Degradation
            current  belief  is  that  the  balance  between  MMPs  and   Cytokines are soluble peptides produced by one cell
            TIMP is important to prevent progression of articular   affecting the activity of other cell types. Studies of
            cartilage degradation.                             cytokines  in  joint  tissues  suggest  that  IL‐1  and TNFα
              In summary, MMPs are considered to play a major   modulate the synthesis of metalloproteinases by both
            role in articular cartilage degradation. They are secreted   chondrocytes and synovial cells 16,17,117  and are therefore
            as latent proenzymes and activated extracellularly by   important mediators in joint disease. Because IL‐1 and
            serine proteinases. Plasmin may activate stromelysin,   TNFα may be produced by synovial cells,  they may
                                                                                                     17
            which in turn is an important activator of collagenase.   therefore be of importance in the deleterious effects of
            Upregulation of these enzymes in synovial membrane   synovitis on articular cartilage. It is thought that the
            and articular cartilage samples from traumatic equine   normal turnover of the extracellular matrix of the artic­
            joint disease has been demonstrated.  It is also known   ular cartilage is regulated by the chondrocytes under the
                                           110
            that the production of MMPs is upregulated by IL‐1.  control and influence of cytokines and mechanical stim­
                                                               uli. Articular cartilage degradation in association with
                                                               disease represents an exacerbation of these normal pro­
            Prostaglandins
                                                               cesses. It is widely accepted that the cytokine IL‐1
              Prostaglandins (primarily E group) are produced in   induces proteoglycan depletion in articular cartilage by
            inflamed joints and can cause a decrease in the proteo­  either increasing the rate of degradation or decreasing
                                            104
            glycan content of the cartilage matrix.  The presence of   synthesis in association with the release of proteinases
            prostaglandin E  in synovial fluid from inflamed joints   and prostaglandins from chondrocytes (Figure  7.10).
                          2
            has been demonstrated in the horse.  In the author’s   IL‐1 produces its effects by binding with an IL‐1   receptor
                                            105
            laboratory, PGE  measurements are used as an objective   on the cell. The presence of IL‐1 in equine osteoarthritic
                          2
            index of the level of synovitis. 26,43  Actions of PGE  in   joints was first reported by Morris et  al.  An  equine
                                                                                                    72
                                                         2
            joints include vasodilation, enhancement of pain percep­  IL‐1 containing extract was produced by May in 1990. 59
            tion, proteoglycan depletion from cartilage (by both   The significant role of equine IL‐1 has been further
            degradation and inhibition of synthesis), bone deminer­  consolidated, starting with the cDNA sequences for
            alization, and promotion of plasminogen activator   IL‐1α and IL‐1β being constructed. 34,35  After generation
            secretion. PGE  is released from chondrocytes on stimu­  of these DNA sequences, the IL‐1α and IL‐1β recombi­
                        2
            lation of these cells by IL‐1 and TNFα.            nant proteins were purified. Prior to that, only human
                                                               recombinant IL‐1 protein was available. Using equine
                                                               articular cartilage explants, significant proteoglycan
            Oxygen‐Derived Free Radicals
                                                               release was induced by both rEq‐IL‐1α and rEq‐IL‐1β at
              Oxygen‐derived free radicals, including superoxide   concentrations greater than or equal to 0.01 ng/mL with
            anion, hydroxyl radicals, and hydrogen peroxide, may   38%–76% and 88%–90% of total GAG released by
            be released from injured joint tissues. Studies have   4 and 6 days, respectively. 42,104  Significant inhibition of
   841   842   843   844   845   846   847   848   849   850   851